Brand name: TENOFIR-300
Composition:
Each tablet contains:
Tenofovir Disoproxil Fumarate……………………………………….300mg
Indication:
• HIV infection, in combination with other antiretrovirals.
• Post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP), in combination with Lamivudine (3TC) or Emtricitabine (FTC).
Dosage:
• Child 35kg and over and adult: 300mg once daily.
• Duration of treatment depends on the efficacy and tolerance of tenofovir.
Contraindications:
• Administer with caution in patients with renal impairment.
• Monitor renal function, in event of deterioration of renal function, switch to another antiretroviral.
• Avoid combination with (or monitor renal function in the event of combination) with nephrotoxic drugs: aminoglycosides (e.g., Gentamicin, Streptomycin), Amphotericin B, Pentamidine, etc.
Warning:
• Administer with caution and monitor use with NSAIDs.
Adverse effects:
• May cause gastrointestinal disturbances (nausea, vomiting, diarrhea, etc.), dizziness, fatigue, skin rash, renal impairment, bone loss (osteoporosis, fractures), pancreatitis.
Dosage form: White tablet
Expiry date：24 months after date of manufacture.
Packaging: 1 bottle containing 30 tablets
Storage:
• Store at room temperature (under 25ᵒC), protected from moisture and direct sunlight away from children.
DISCLAIMER
The information on this website about our medications is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
For your safety:
Do not self-diagnose or treat any medical condition based solely on the information on this website. If you have any questions or concerns about a medication, please talk to your doctor or pharmacist.
